Drugs /

triciribine

Back to Drugs List

Overview

Clinical Trials

View Clinical Trials for triciribine

Triciribine has been investigated in 2 clinical trials, of which 1 is open and 1 is closed. Of the trials investigating triciribine, 2 are phase 1/phase 2 (1 open).

Acute lymphoblastic leukemia, acute myeloid leukemia, and chronic myeloid leukemia are the most common diseases being investigated in triciribine clinical trials [2].

Drug Details

Synonyms [2]:
triciribine, pentaazacentopthylene, 1,4,5,6,8-pentaazaacenaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-d-ribofuranosyl-
Drug Target(s) [2]:
AKT1, AKT2, AKT3
NCIT ID [1]:
C142998

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.